Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, premixes, food and beverage fortification, veterinary, feed, and rodenticides; pharmaceutical ingredients comprising phenyramidol and silicon dry powder; nutritional premixes; and enzymes for use in oleochemicals, fine chemicals, active pharmaceutical ingredients, food and fragrances, leather, and biodiesel industries. In addition, it engages in the design, engineering, procurement, and construction of water and wastewater treatment plants; and offers operations and maintenance services, as well as property development business. The company was formerly known as DIL Limited. Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India.
Metrics to compare | FERM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFERMPeersSector | |
---|---|---|---|---|
P/E Ratio | 7.8x | 28.8x | −0.7x | |
PEG Ratio | 0.02 | 0.16 | 0.00 | |
Price/Book | 2.2x | 3.4x | 2.6x | |
Price / LTM Sales | 1.5x | 2.5x | 3.3x | |
Upside (Analyst Target) | - | 19.0% | 37.1% | |
Fair Value Upside | Unlock | 1.1% | 4.7% | Unlock |